ICUI
Price
$157.60
Change
+$3.18 (+2.06%)
Updated
Jul 13 closing price
Capitalization
3.94B
28 days until earnings call
Intraday BUY SELL Signals
NSYS
Price
$13.65
Change
-$0.23 (-1.66%)
Updated
Jul 13 closing price
Capitalization
38.23M
Intraday BUY SELL Signals
Interact to see
Advertisement

ICUI vs NSYS

ICUI vs NSYS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ICUI vs. NSYS commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICUI is a Buy and NSYS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (ICUI: $157.60 vs. NSYS: $13.88)
Brand notoriety: ICUI and NSYS are both not notable
ICUI represents the Pharmaceuticals: Other, while NSYS is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ICUI: 19% vs. NSYS: 61%
Market capitalization -- ICUI: $3.94B vs. NSYS: $38.23M
ICUI [@Pharmaceuticals: Other] is valued at $3.94B. NSYS’s [@Medical/Nursing Services] market capitalization is $38.23M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $144.19B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $160.44B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $7.95B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICUI’s FA Score shows that 0 FA rating(s) are green whileNSYS’s FA Score has 0 green FA rating(s).

  • ICUI’s FA Score: 0 green, 5 red.
  • NSYS’s FA Score: 0 green, 5 red.
According to our system of comparison, NSYS is a better buy in the long-term than ICUI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICUI’s TA Score shows that 4 TA indicator(s) are bullish while NSYS’s TA Score has 3 bullish TA indicator(s).

  • ICUI’s TA Score: 4 bullish, 4 bearish.
  • NSYS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ICUI is a better buy in the short-term than NSYS.

Price Growth

ICUI (@Pharmaceuticals: Other) experienced а -1.15% price change this week, while NSYS (@Medical/Nursing Services) price change was -4.60% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.39%. For the same industry, the average monthly price growth was +7.29%, and the average quarterly price growth was -8.66%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +7.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was -13.46%.

Reported Earning Dates

ICUI is expected to report earnings on Aug 10, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-2.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+7.49% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICUI($3.94B) has a higher market cap than NSYS($38.2M). ICUI has higher P/E ratio than NSYS: ICUI (84.73) vs NSYS (36.00). NSYS YTD gains are higher at: 83.838 vs. ICUI (10.465). ICUI has higher annual earnings (EBITDA): 299M vs. NSYS (3.88M). ICUI has more cash in the bank: 288M vs. NSYS (1.96M). NSYS has less debt than ICUI: NSYS (18M) vs ICUI (1.33B). ICUI has higher revenues than NSYS: ICUI (2.16B) vs NSYS (122M).
ICUINSYSICUI / NSYS
Capitalization3.94B38.2M10,312%
EBITDA299M3.88M7,708%
Gain YTD10.46583.83812%
P/E Ratio84.7336.00235%
Revenue2.16B122M1,768%
Total Cash288M1.96M14,664%
Total Debt1.33B18M7,367%
FUNDAMENTALS RATINGS
ICUI vs NSYS: Fundamental Ratings
ICUI
NSYS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
10069
SMR RATING
1..100
9089
PRICE GROWTH RATING
1..100
4444
P/E GROWTH RATING
1..100
10035
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NSYS's Valuation (59) in the Electronic Components industry is in the same range as ICUI (67) in the Medical Specialties industry. This means that NSYS’s stock grew similarly to ICUI’s over the last 12 months.

NSYS's Profit vs Risk Rating (69) in the Electronic Components industry is in the same range as ICUI (100) in the Medical Specialties industry. This means that NSYS’s stock grew similarly to ICUI’s over the last 12 months.

NSYS's SMR Rating (89) in the Electronic Components industry is in the same range as ICUI (90) in the Medical Specialties industry. This means that NSYS’s stock grew similarly to ICUI’s over the last 12 months.

NSYS's Price Growth Rating (44) in the Electronic Components industry is in the same range as ICUI (44) in the Medical Specialties industry. This means that NSYS’s stock grew similarly to ICUI’s over the last 12 months.

NSYS's P/E Growth Rating (35) in the Electronic Components industry is somewhat better than the same rating for ICUI (100) in the Medical Specialties industry. This means that NSYS’s stock grew somewhat faster than ICUI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ICUINSYS
RSI
ODDS (%)
Bearish Trend 4 days ago
60%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 4 days ago
83%
Momentum
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
77%
MACD
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
71%
Bearish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
72%
Advances
ODDS (%)
Bullish Trend 12 days ago
67%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 21 days ago
72%
Bearish Trend 20 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
85%
Aroon
ODDS (%)
Bullish Trend 4 days ago
70%
Bearish Trend 4 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
ICUI
Daily Signal:
Gain/Loss:
NSYS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPDV39.400.18
+0.45%
AAM S&P 500 High Dividend Value ETF
FLXR38.90-0.08
-0.22%
TCW Flexible Income ETF
BKFI23.62-0.08
-0.36%
BNY Mellon Active Core Bond ETF
VIOO134.41-0.58
-0.43%
Vanguard S&P Small-Cap 600 ETF
BIBL55.89-0.43
-0.76%
Inspire 100 ETF

NSYS and

Correlation & Price change

A.I.dvisor tells us that NSYS and STRR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NSYS and STRR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NSYS
1D Price
Change %
NSYS100%
-1.66%
STRR - NSYS
29%
Poorly correlated
+0.36%
POCI - NSYS
26%
Poorly correlated
-3.61%
STRRP - NSYS
23%
Poorly correlated
+0.70%
LH - NSYS
23%
Poorly correlated
-0.05%
ICUI - NSYS
23%
Poorly correlated
+2.06%
More